期刊文献+

云南白药与锡类散保留灌肠联合口服美沙拉嗪治疗溃疡性结肠炎的疗效观察 被引量:12

下载PDF
导出
摘要 目的探讨应用云南白药与锡类散保留灌肠联合口服美沙拉嗪药物治疗溃疡性结肠炎的临床疗效。方法将124例病人随机分为A组和B组,A组(62例):云南白药1.0、锡类散1.0、庆大霉素16万单位、10%利多卡因10ml保留灌肠1次/d,美沙拉嗪肠溶片1.0g4次/d口服;B组(62例):美沙拉嗪1.0g4次/d口服;疗程均为3周。结果治疗3周后A组和B组临床总有效率分别是90.3%和71.0%,结肠镜下炎症总改善率分别是93.5%和67.7%;A组和B组相比差异明显(P<0.05)。两组不良反应发生率差异无统计学意义(P>0.05)。3月后了解复发情况,A组2例复发,B组6例复发。结论云南白药与锡类散保留灌肠联合口服美沙拉嗪药物治疗优于单一口服美沙拉嗪药物。
出处 《现代消化及介入诊疗》 2012年第4期231-232,共2页 Modern Interventional Diagnosis and Treatment in Gastroenterology
  • 相关文献

参考文献2

二级参考文献18

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247. 被引量:5
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154. 被引量:3
  • 3Sandborn W J,Hanauer S B.Systematic Review:the Pharma2 Cokinetic Profiles of Oral Mesalazine Formulations and Mesalazine pro-drugs Used in the Management of Ulcerative Colitis[J].Aliment pharmacol Ther,2003,17 (1):29-42. 被引量:1
  • 4Schroeder K W.Role of Mesalazine in Acute and Long-term Treatment of Ulcerative Colitis and Its Complications[J].Scand J Gastroenterol Suppl,2002,236:42-47. 被引量:1
  • 5樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278. 被引量:3
  • 6欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84. 被引量:4
  • 7Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413. 被引量:1
  • 8Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753. 被引量:1
  • 9Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75. 被引量:1
  • 10Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643. 被引量:1

共引文献1036

同被引文献102

  • 1程冕.溃疡性结肠炎合并虹膜睫状体炎1例报告[J].实用医院临床杂志,2008,5(2). 被引量:1
  • 2Yu-Fang Wang,Qin Ou-yang,Bing Xia,Li-Na Liu,Fang Gu,Kai-Fang Zhou,Qiao Mei,Rui-Hua Shi,Zhi-Hua Ran,Xiao-Di Wang,Pin-Jin Hu,Kai-Chun Wu,Xin-Guang Liu,Ying-Lei Miao,Ying Han,Xiao-Ping Wu,Guo-Bing He,Jie Zhong,Guan-Jian Liu.Multicenter case-control study of the risk factors for ulcerative colitis in China[J].World Journal of Gastroenterology,2013,19(11):1827-1833. 被引量:25
  • 3陈凡,张志坚.67例溃疡性结肠炎的临床分析[J].胃肠病学和肝病学杂志,2006,15(4):430-430. 被引量:9
  • 4欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 5中华中医药学会.中医肛肠科常见病诊疗指南[M].北京:中国中医药出版社,2012: 33. 被引量:44
  • 6陈灏珠,钟南山,陆再英.内科学[M].8版.北京:人民卫生出版社,2013:624-626. 被引量:87
  • 7Kleiveland CR, Hult LT, Spetalen S, et al.The noncommensal bac- terium Methylococcus capsulatus (Bath) ameliorates dextran sulfate (sodium salt)-induced ulcerative colitis by influencing mechanisms essential for maintenance of the colonic barrier function. Appl En- viron Microbiol, 2013,79(1):48-56. 被引量:1
  • 898全国腹泻病防治学术研讨会组委会.98全国腹泻病防治学术研讨会会议纪要.中华儿科杂志,1999,37(4):239-239. 被引量:1
  • 9Vidal-Casariego A, Calleja-FemtSndez A, DeUrbina-Gonz~tlez JJ, et al. Efficacy of glutamine in the prevention of acute radiation en- teritis: A randomized controlled trial. JPEN J Parenter Enteral Nutr, 2014,38(2):205-213. 被引量:1
  • 10Bickelhaupt S, Wumig M, Boss A, et al. Correlation between mor- phologicai expansion and impairment of intra- and prelesionary motility in inflammatory small bowel lesions in patients with Crohn' s disease - preliminary data. Eur J Radiol, 2014,83(7): 1044-1050. 被引量:1

引证文献12

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部